Поиск

Материалов:
980 144

Репозиториев:
30

Авторов:
596 024

Автор

Ключевое слово

Тип статьи

DOI

ORCID

Дополнительно:

Период публикации

Репозиторий

По вашему запросу найдено документов: 25324

Страница 3 из 2533

Contrast-induced acute kidney injuryafter delayed percutaneous coronary intervention:prognostic value and outcomes

Gaskina A.A., Mayskov V.V., Villevalde S.V., Kobalava Z.D.

elevation myocardial infarction (UA/NSTEMI).Material and methods. 236 patients with UA/NSTEMI and delayed

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

on Acute Coronary Syndromes–ST Elevation Myocardial Infarction (ISACS-STEMI) COVID-19. Methods: The ISACS

ОСОБЕННОСТИ РЕМОДЕЛИРОВАНИЯ ЛЕВОГО ЖЕЛУДОЧКА У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ И БЕЗ ПОДЪЕМА СЕГМЕНТА ST

Закирова, Н.Э., Казиева, З.А., Закирова, А.Н., Zakirova, N.E., Kazieva, Z.A., Zakirova, A.N.

(STEMI) and non-ST segment elevation (non-STEMI) myocardial infarction (MI). Materials and methods

Маркеры гемодинамического стресса и развитие неблагоприятного ремоделирования левого желудочка у пациентов с инфарктом миокарда с подъемом сегмента ST

Рябова, Тамара Ростиславовна, Гусакова, Анна Михайловна, Суслова, Татьяна Евгеньевна, Рябов, Вячеслав Валерьевич, Карпов, Ростислав Сергеевич, Керчева, Мария Анатольевна

elevation myocardial infarction

THE PROGNOSTING VALUE OF COMBING NEW BIOMARKERS FOR REMOTE CARDIOVASCULAR ENDPOINTS RISK STRATIFICATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

ZAGIDULLIN, N.SH., HAMITOVA, A., LAKMAN, I., KRIONI, I., GAREEVA, D., ZULKARNEEV, R., TULBAEV, E.

The biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools

Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance

Dongworth R., Campbell-Washburn A., Cabrera-Fuentes H., Bulluck H., Roberts T., Price A., Hernández-Reséndiz S., Ordidge R., Thomas D., Yellon D., Lythgoe M., Hausenloy D.

quantify the area-at-risk (AAR) following acute myocardial infarction (AMI), and has been used to assess

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

Iglesias J.F., Roffi M., Muller O., Eeckhout E., Heg D., Losdat S., Zwahlen M., Kurz D.J., Moarof I., Weilenmann D., Kaiser C., Tapponnier M., Stortecky S., Valgimigli M., Windecker S., Pilgrim T., Odutayo A., Jüni P.

durable polymer everolimus-eluting stents in patients with acute ST-segment elevation myocardial

Contrast-induced acute kidney injury after primary percutaneous coronary interventions: Prevalence, predictive factors, and outcomes

Kobalava Zh.D., Villevalde S.V., Gaskina A.A., Mayskov V.V., Moiseev V.S.

-induced acute kidney injury (CIAKI) in patients with ST-segment elevation acute coronary syndrome (STSEACS), who

TYPE 2 MYOCARDIAL INFARCTION: CLINICAL AND DEMOGRAPHIC FEATURES, LABORATORY AND INSTRUMENTAL ASSOCIATIONS

Hoang H.T., Kitbalyan A.A., Lazarev P.V., Maiskov V.V., Shkolinikova E.E., Meray I.A.

present without ST segment elevation (p = 0.001) and have lower troponin values (p = 0.001). They also had

Fortelyzin® in comparison with metalyse® for ST-elevated myocardial infarction: One-year results and clinical outcomes of a multicenter randomized study FRIDOM1

Markov V.A., Duplyakov D.V., Konstantinov S.L., Klein G.V., Aksentev S.B., Platonov D.Y., Vyshlov E.V., Ponomarev E.A., Rabinovich R.M., Makarov E.L., Kulibaba E.V., Yunevich D.S., Kritskaia O.V., Baranov E.A., Talibov O.B., Gerasimets E.A.

of the Russian Federation in the period 2014-2016. The study included 382 patients with acute ST-elevated

Страница 3 из 2533